We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

48 hedge funds and large institutions have $13.9M invested in Perspective Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 1.31% → 1.23% (-0.08%)

16% less funds holding

Funds holding: 57 → 48 (-9)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

31% less capital invested

Capital invested by funds: $20.2M → $13.9M (-$6.32M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
48
Holders Change
-9
Holders Change %
-15.79%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
11
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$445K
2
PCM
Perkins Capital Management
Minnesota
+$223K
3
BA
Bard Associates
Illinois
+$135K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$118K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$65.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$595K
2
BlackRock
BlackRock
New York
-$506K
3
BCM
Bridgeway Capital Management
Texas
-$228K
4
MS
Maven Securities
Jersey
-$167K
5
VF
Virtu Financial
New York
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBNA
26
Bremer Bank National Association
Minnesota
$23K – – –
RJFSA
27
Raymond James Financial Services Advisors
Florida
$20K +$1.75K +200 +9%
Victory Capital Management
28
Victory Capital Management
Texas
$18K -$569 -65 -3%
S
29
SignatureFD
Georgia
$18K +$19.7K +2,250 New
TWM
30
TMD Wealth Management
Arizona
$16K – – –
AAM
31
Auxier Asset Management
Oregon
$11K – – –
CAI
32
Capital Advisors Inc
Oklahoma
$8K – – –
SWP
33
Stratos Wealth Partners
Ohio
$8K – – –
Wells Fargo
34
Wells Fargo
California
$5K -$9 -1 -0.2%
JFA
35
JNBA Financial Advisors
Minnesota
$4K – – –
HI
36
Harbour Investments
Wisconsin
$2K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$1K -$3.04K -347 -78%
Osaic Holdings
38
Osaic Holdings
Arizona
$1K – – –
UBS Group
39
UBS Group
Switzerland
$1K – – –
WQ
40
Wealth Quarterback
New Jersey
$1K +$114 +13 New
ASN
41
Advisory Services Network
Georgia
$1K +$876 +100 New
AIA
42
Arcadia Investment Advisors
Idaho
$177 – – –
MS
43
Maven Securities
Jersey
– -$167K -15,000 Closed
California Public Employees Retirement System
44
California Public Employees Retirement System
California
– -$128K -11,710 Closed
CWM
45
Cahaba Wealth Management
Georgia
– -$114K -10,500 Closed
Two Sigma Investments
46
Two Sigma Investments
New York
– -$69K -6,349 Closed
Two Sigma Advisers
47
Two Sigma Advisers
New York
– -$56K -5,170 Closed
Capstone Investment Advisors
48
Capstone Investment Advisors
New York
– -$55K -5,047 Closed
IFS
49
Ifrah Financial Services
Arkansas
– -$33K -3,000 Closed
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
– -$28K -2,534 Closed
1
2
3

CATX Hedge Fund Activity: Q2 2021 in Review

48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2021, worth a combined $13.9M — down 31% from $20.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CATX and 8 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was State Street, adding an estimated $445K. The largest seller was Renaissance Technologies, cutting an estimated $595K.

  • 48 institutional investors held Perspective Therapeutics (CATX) as of Q2 2021, down from 57 in Q1 2021.
  • Funds reported $13.9M of Perspective Therapeutics stock for Q2 2021, down 31% quarter-over-quarter.
  • 8 funds opened new Perspective Therapeutics positions in Q2 2021 and 17 closed out, a net change of -9 holders.
  • The largest Perspective Therapeutics buyer in Q2 2021 was State Street, an estimated $445K added.
  • The largest Perspective Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $595K sold.

Based on aggregated 13F filings for Q2 2021.